Shortage of antiseizure medication in Germany: How big is the problem?
11% to 15% of ASM formulations had drug shortages in Germany in July 2023. Generic ASM were more frequently affected than brand-name ASM. About 2/3 of manufacturers were reported to have drug shortages.
Authors
- Hajo M. Hamer (ORCID: https://orcid.org/0000-0003-1709-8617)
- Josephine Steidl
- Karel Kostev (ORCID: https://orcid.org/0000-0002-2124-7227)
- Stefan Schwab (ORCID: https://orcid.org/0000-0002-8487-1238)
- Sabine Krebs
Institutions
- Universitätsklinikum Erlangen (DE)
- Fraport (Germany) (DE)
Publication Details
- Journal
- Epilepsy & Behavior
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1016/j.yebeh.2024.110162
- Citations
- 3
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 3.33
Funders
- Pfizer
- Alnylam Pharmaceuticals
- LivaNova
- Bundesinstitut für Arzneimittel und Medizinprodukte
- Eisai
- UCB Pharma